Axela Acquires Xceed Molecular to Bolster Biomarker Discovery Business

Axela to date has focused on providing protein analysis tools and services, and the addition of Xceed's Ziplex System for gene expression analysis will support its ambitions to speed the validation and clinical application of DNA, RNA, and protein biomarkers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.